The development of a prototype innovative interactive online platform for clinical trials

临床试验原型创新互动在线平台的开发

• 批准号: 720184
• 金额: $ 6.34万
• 依托单位: TOMORROWS MEDICINES LIMITED
• 依托单位国家: 英国
• 项目类别: GRD Development of Prototype
• 财政年份: 2013
• 资助国家: 英国
• 起止时间: 2013 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=720184
• 关键词: development; prototype; innovative; interactive; online

The proposed solution will be the development of an intelligent cloud-based recruitment and communication platform for connecting healthcare professionals, scientists, research nurses, trial coordinators and patients for better knowledge access and transfer on clinical trials.Called “www.YourTreatmentChoices.com”, the platform allows patients to watch and listen to videos of research doctors explaining the purpose and requirements of individual trials and the facility to engage directly with research teams. The innovativeness of the solution lies within developing an automated screening tool for selecting patients using data mining.Various cases of medical treatments in the NHS no longer prove effective for patients. With average timelines for innovations in the NHS of 17 years, the improvement of access and availability to new treatment trials is vital for increased trials successes and innovations in the NHS. Current trial failures are due to the challenge of recruiting patients resulting in 4 trials out of 10 non-completed. With a patient recruitment target of 125,000 per quarter year by 2014, the market in the UK represents a strong opportunity. The cost of running clinical trials in the UK amounts up to 30% of pharmaceutical companies’ drug development budget, consuming approximately 40% of total clinical trial costs with time being a prime cause for 70% of clinical trial failures. While enabling pharmaceutical companies to significantly reduce the cost and time of clinical trials, the platform will encourage patients to take an active role in managing their own disease through better education means about their conditions and treatment availability. With this the project will not only help to meet patient recruitment targets on time and costs but improve the opportunities of new treatments and medical research in the UK. The project will deliver direct value to the pharmaceutical sector, benefiting the overall UK healthcare research and economy.

拟议的解决方案将是开发一个基于智能云的招聘和沟通平台，用于连接医疗保健专业人员、科学家、研究护士、试验协调员和患者，以更好地获取和传递临床试验的知识。该平台名为www.YourTreatmentChoices.com，允许患者观看和收听研究医生解释个别试验的目的和要求的视频，以及直接与研究团队互动的设施。该解决方案的创新之处在于开发了一种使用数据挖掘来选择患者的自动筛查工具。事实证明，NHS中的各种医疗病例对患者不再有效。由于国民保健制度创新的平均时间为17年，改善获得新治疗试验的机会和可获得性对于增加国民保健制度试验的成功和创新至关重要。目前的试验失败是由于招募病人的挑战，导致10项试验中有4项未完成。到2014年，耐心招聘的目标是每年每季度12.5万人，英国市场代表着一个强大的机会。在英国进行临床试验的成本高达制药公司药物开发预算的30%，消耗了大约40%的临床试验成本，而时间是70%临床试验失败的主要原因。在使制药公司能够大幅减少临床试验的成本和时间的同时，该平台将鼓励患者通过更好的关于他们的病情和治疗可获得性的教育手段，在管理他们自己的疾病方面发挥积极的作用。通过这一项目，该项目不仅将有助于在时间和成本上满足患者招募目标，而且还将改善英国新疗法和医学研究的机会。该项目将为制药行业带来直接价值，使英国整体医疗研究和经济受益。